期刊
ARCHIV DER PHARMAZIE
卷 353, 期 6, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ardp.201900380
关键词
antibacterial; coumarin; hybrid compounds; structure-activity relationships
资金
- Natural Science Foundations of China [U1812403] Funding Source: Medline
- Research and Innovation Team of Hunan University of Medicine [2019-48] Funding Source: Medline
Infections caused by Gram-positive and -negative bacteria are one of the foremost causes of morbidity and mortality globally. Antibiotics are the mainstay of therapy for bacterial infections, but the emergence and wide spread of drug-resistant pathogens have already become a huge issue for public healthcare systems. The coumarin moiety, which is ubiquitous in nature, could bind to the B subunit of DNA gyrase in bacteria and inhibit DNA supercoiling by blocking the ATPase activity; hence, coumarin derivatives possess potential antibacterial activity. Several coumarin-containing hybrids such as coumermycin A1, clorobiocin, and novobiocin have already been used in clinical practice for the treatment of various bacterial infections; thus, it is conceivable that hybridization of the coumarin moiety with other antibacterial pharmacophores may provide opportunities for the development of novel antibiotics. This review outlines the advances in coumarin-containing hybrids with antibacterial potential in the recent 5 years and the structure-activity relationships are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据